Publications en collaboration avec des chercheurs de Fundación Hospital Alcorcón (31)

2024

  1. Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 8, pp. 1288-1298

  2. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

  3. Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

  2. Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy

    Kidney International Reports, Vol. 8, Núm. 8, pp. 1596-1604

  3. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes

    Clinical Kidney Journal, Vol. 16, Núm. 10, pp. 1656-1663

2022

  1. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137

  2. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  3. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153

  4. IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy

    Kidney International Reports, Vol. 7, Núm. 4, pp. 831-840

  5. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

2021

  1. The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease

    Kidney International Reports, Vol. 6, Núm. 9, pp. 2392-2403

  2. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Kidney International, Vol. 99, Núm. 4, pp. 986-998

  3. The authors reply

    Kidney International

  4. The authors reply

    Kidney International

  5. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease

    Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298

  2. Risk factors for non-diabetic renal disease in diabetic patients

    Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388

2019

  1. Acute kidney injury in interstitial nephritis

    Current Opinion in Critical Care, Vol. 25, Núm. 6, pp. 558-564

2017

  1. Renal vasculitis presenting with acute kidney injury

    Rheumatology International, Vol. 37, Núm. 6, pp. 1035-1041